{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:02:32Z","timestamp":1784952152460,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22105229"],"award-info":[{"award-number":["22105229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972488"],"award-info":[{"award-number":["81972488"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bioorg.2023.106926","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T12:10:41Z","timestamp":1697803841000},"page":"106926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage"],"prefix":"10.1016","volume":"141","author":[{"given":"Shuyi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiHao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2023.106926_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106926_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106926_b0015","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2023.106926_b0020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41585-018-0060-7","article-title":"Landmarks in prostate cancer","volume":"15","author":"Sathianathen","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106926_b0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106926_b0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000519861","article-title":"Metastatic prostate cancer: treatment options","volume":"100","author":"Achard","year":"2022","journal-title":"Oncology"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106926_b0035","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/biomedicines9091247","article-title":"Current and emerging therapies for metastatic castration-resistant prostate cancer (mCRPC)","volume":"9","author":"Henr\u00edquez","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106926_b0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/cancers13020334","article-title":"Immunotherapy and immunotherapy combinations in metastatic castration-resistant prostate cancer","volume":"13","author":"Bansal","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106926_b0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3390\/biomedicines10030537","article-title":"Immunotherapy in advanced prostate cancer: current knowledge and future directions","volume":"10","author":"L\u00f3pez-Campos","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2023.106926_b0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/RRU.S360444","article-title":"Treatment landscape for patients with castration-resistant prostate cancer: patient selection and unmet clinical needs","volume":"14","author":"Turco","year":"2022","journal-title":"Research and Reports in Urology"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106926_b0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40265-019-01247-1","article-title":"Dolutegravir\/Lamivudine Single-Tablet Regimen: A Review in HIV-1 infection","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"issue":"14","key":"10.1016\/j.bioorg.2023.106926_b0060","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s40265-013-0121-4","article-title":"Dolutegravir: first global approval","volume":"73","author":"Ballantyne","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2023.106926_b0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2019.04.043","article-title":"Antibacterial activity study of 1,2,4-triazole derivatives","volume":"173","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106926_b0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/mmy\/myaa061","article-title":"8-Hydroxyquinoline 1,2,3-triazole derivatives with promising and selective antifungal activity","volume":"59","author":"da Silva","year":"2021","journal-title":"Med. Mycol."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106926_b0075","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2174\/138955710791608316","article-title":"Triazole nucleoside derivatives bearing aryl functionalities on the nucleobases show antiviral and anticancer activity","volume":"10","author":"Xia","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106926_b0080","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1007\/s11030-021-10321-4","article-title":"Synthesis and insecticidal activity of novel 1,2,4-triazole derivatives containing trifluoroacetyl moieties","volume":"26","author":"Zhao","year":"2022","journal-title":"Mol. Divers."},{"issue":"16","key":"10.1016\/j.bioorg.2023.106926_b0085","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","article-title":"1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: a recent overview","volume":"27","author":"Bozorov","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106926_b0090","doi-asserted-by":"crossref","first-page":"e2100158","DOI":"10.1002\/ardp.202100158","article-title":"1,2,3-Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch. Pharm."},{"issue":"17","key":"10.1016\/j.bioorg.2023.106926_b0095","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2174\/1568026622666220415225334","article-title":"1,2,3-triazole derivatives with anti-breast cancer potential","volume":"22","author":"Wu","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106926_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111700","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms and structure-activity relationships","volume":"183","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106926_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105129","article-title":"Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway","volume":"161","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106926_b0110","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ccell.2020.05.022","article-title":"SETD2 restricts prostate cancer metastasis by integrating EZH2 and AMPK signaling pathways","volume":"38","author":"Yuan","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2023.106926_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114851","article-title":"Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer","volume":"244","author":"Alt\u0131ntop","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106926_b0120","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ijc.33918","article-title":"PARP mediated DNA damage response, genomic stability and immune responses","volume":"150","author":"Zong","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"13","key":"10.1016\/j.bioorg.2023.106926_b0125","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1093\/nar\/gks287","article-title":"Genome-wide profiles of H2AX and gamma-H2AX differentiate endogenous and exogenous DNA damage hotspots in human cells","volume":"40","author":"Seo","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2023.106926_b0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.dnarep.2018.08.021","article-title":"Mechanisms of PARP inhibitor sensitivity and resistance","volume":"71","author":"D'Andrea","year":"2018","journal-title":"DNA Repair"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823005874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823005874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:56:59Z","timestamp":1758617819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823005874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":26,"alternative-id":["S0045206823005874"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106926","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106926"}}